RE:RE:RE:RE:Luc hints that there is some reluctance in adopting Trogarzo Always good to have your drug’s article published in the NEJM.
We routinely dissect these articles at grand rounds so the word will get out to all Physicians about Ibalizumab.
It is free advertising and it is the best kind. Thera can also drop off the article(s) when they detail individual HIV docs.
Bfw
SPCEO1 wrote: I don't think there was any new ground broken in these articles. All of it has been talked about here some time ago. Having NEJM articles that are positive about your drug is a helpful thing, but I doubt it moves the sales meter significantly. For any who might have been questioning the data, it will help alleviate their concerns. But there likely are very few such doctors anyway.